Assignee profile:

Metaproteomics, LLC

City:

San Clemente, California

Country:

United States

Published Applications:

56

Last publication date:

2013-06-20

Patent Grants:

34

Last grant date:

2019-03-05

Top Inventors for applications by Metaproteomics, LLC

These are the the leading inventors for applications assigned to Metaproteomics, LLC:

Recent patent applications by Metaproteomics, LLC

Metaproteomics, LLC based in San Clemente, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2013-06-20 ✅ Patent 10,220,068 granted on 2019-03-05
US20130156870A1
Human necessities

Phytonutrient compositions and methods to protect against radical mediated cellular and DNA damage

#2 | 2013-03-14
US20130064913A1
Human necessities

ANTI-INFLAMMATORY BOTANICAL PRODUCTS FOR THE TREATMENT OF METABOLIC SYNDROME AND DIABETES

#3 | 2012-10-25 ✅ Patent 8,557,306 granted on 2013-10-15
US20120270837A1
Human necessities

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#4 | 2012-07-26 ✅ Patent 8,475,850 granted on 2013-07-02
US20120189721A1
Chemistry; metallurgy

Methods and compositions for heavy metal detoxification

#5 | 2012-07-19 ✅ Patent 8,257,754 granted on 2012-09-04
US20120183634A1
Human necessities

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#6 | 2012-07-12
US20120177756A1
Human necessities

Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response

#7 | 2012-03-27 ✅ Patent 8,142,819 granted on 2012-03-27
US10464410
-

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#8 | 2011-11-10
US20110275721A1
Chemistry; metallurgy

METHOD FOR THE PURIFICATION OF SUBSTITUTED CYCLOPENT-2-EN-1-ONE CONGENERS AND SUBSTITUTED 1,3-CYCLOPENTADIONE CONGENERS FROM A COMPLEX MIXTURE USING COUNTERCURRENT SEPARATION

#9 | 2011-10-20
US20110257074A1
Chemistry; metallurgy

METHOD FOR THE PURIFICATION OF SUBSTITUTED CYCLOPENT-2-EN-1-ONE CONGENERS AND SUBSTITUTED 1,3-CYCLOPENTADIONE CONGENERS FROM A COMPLEX MIXTURE USING COUNTERCURRENT SEPARATION

#10 | 2011-07-14 ✅ Patent 8,193,201 granted on 2012-06-05
US20110172253A1
Human necessities

Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines

#11 | 2011-06-09
US20110136917A1
Physics

TETRAHYDRO-ISOALPHA ACID COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT

#12 | 2011-06-09
US20110135768A1
Human necessities

DIHYDRO-ISOALPHA ACID AND ACACIA NILOTICA EXTRACT BASED COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT

#13 | 2011-01-27 ✅ Patent 7,919,125 granted on 2011-04-05
US20110021638A1
Human necessities

Modulation of inflammation by hops fractions and derivatives

#14 | 2011-01-27
US20110021637A1
Human necessities

XANTHOHUMOL AND TETRAHYDRO-ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT

#15 | 2010-09-02
US20100222262A1
Chemistry; metallurgy

SUBSTITUTED 1, 3-CYCLOPENTADIONE ATTENUATED ENDOTHELIAL INFLAMMATION AND ENDOTHELIAL-MONOCYTE INTERACTIONS

#16 | 2010-08-26
US20100215782A1
Human necessities

NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS

#17 | 2010-07-22 ✅ Patent 7,807,203 granted on 2010-10-05
US20100184857A1
Human necessities

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

#18 | 2010-06-03
US20100137449A1
Human necessities

SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH

#19 | 2010-05-06
US20100112099A1
Human necessities

PHYTOCHEMICAL COMPOSITIONS AND METHODS FOR ACTIVATING AMP-KINASE

#20 | 2010-03-18
US20100069422A1
Human necessities

METHODS AND COMPOSITIONS FOR PROMOTING BONE AND JOINT HEALTH

#21 | 2009-06-18 ✅ Patent 8,241,674 granted on 2012-08-14
US20090155382A1
Chemistry; metallurgy

Methods and compositions for heavy metal detoxification

#22 | 2009-05-07 ✅ Patent 7,901,713 granted on 2011-03-08
US20090118373A1
Human necessities

Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops

#23 | 2008-10-09
US20080248131A1
Human necessities

Protein Kinase Modulation by Hops and Acacia Products

#24 | 2008-10-02 ✅ Patent 8,815,306 granted on 2014-08-26
US20080242690A1
Human necessities

Methods and compositions for promoting bone and joint health

#25 | 2008-02-28
US20080051466A1
Human necessities

Isoalpha acid based protein kinase modulation cancer treatment

#26 | 2008-02-28 ✅ Patent 7,736,677 granted on 2010-06-15
US20080051465A1
Human necessities

Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

#27 | 2008-02-19 ✅ Patent 7,332,185 granted on 2008-02-19
US10280198
-

Complex mixtures exhibiting selective inhibition of cyclooxygenase-2

#28 | 2008-02-07
US20080033057A1
Human necessities

Hexahydro-isoalpha acid based protein kinase modulation cancer treatment

#29 | 2008-02-07
US20080033056A1
Human necessities

Xanthohumol based protein kinase modulation cancer treatment

#30 | 2008-02-07
US20080031986A1
Human necessities

Protein kinase modulation by hops and acacia products

#31 | 2008-02-07
US20080031982A1
Human necessities

Tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

#32 | 2008-02-07
US20080031894A1
Human necessities

Beta acid based protein kinase modulation cancer treatment

#33 | 2008-02-07
US20080031893A1
Human necessities

Acacia based protein kinase modulation cancer treatment

#34 | 2008-01-31
US20080026088A1
Human necessities

Reduced isoalpha acid based protein kinase modulation cancer treatment

#35 | 2007-12-06 ✅ Patent 8,206,753 granted on 2012-06-26
US20070281045A1
Human necessities

Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes

#36 | 2007-09-18 ✅ Patent 7,270,835 granted on 2007-09-18
US10689856
-

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#37 | 2007-08-30 ✅ Patent 7,811,610 granted on 2010-10-12
US20070202208A1
Human necessities

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

#38 | 2007-08-09 ✅ Patent 8,092,846 granted on 2012-01-10
US20070185213A1
Human necessities

Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines

#39 | 2007-08-09 ✅ Patent 8,168,234 granted on 2012-05-01
US20070184133A1
Human necessities

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#40 | 2007-07-26
US20070172532A1
Human necessities

Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2

#41 | 2007-07-19 ✅ Patent 7,901,714 granted on 2011-03-08
US20070166418A1
Human necessities

Treatment modalities for autoimmune diseases

#42 | 2007-07-12 ✅ Patent 8,486,457 granted on 2013-07-16
US20070160692A1
Human necessities

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#43 | 2007-06-21 ✅ Patent 7,682,636 granted on 2010-03-23
US20070141183A1
Human necessities

Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2

#44 | 2007-04-17 ✅ Patent 7,205,151 granted on 2007-04-17
US9885721
-

Complex mixtures exhibiting selective inhibition of cyclooxygenase-2

#45 | 2007-01-25 ✅ Patent 7,718,198 granted on 2010-05-18
US20070020352A1
Human necessities

Treatment modalities for autoimmune diseases

#46 | 2006-08-31 ✅ Patent 7,794,757 granted on 2010-09-14
US20060193933A1
Human necessities

Modulation of inflammation by hops fractions and derivatives

#47 | 2006-08-10 ✅ Patent 7,431,948 granted on 2008-10-07
US20060177531A1
Human necessities

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#48 | 2006-06-29 ✅ Patent 7,815,944 granted on 2010-10-19
US20060141082A1
Human necessities

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity

#49 | 2006-06-29 ✅ Patent 7,666,449 granted on 2010-02-23
US20060141081A1
Human necessities

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

#50 | 2006-06-15 ✅ Patent 7,790,205 granted on 2010-09-07
US20060127517A1
Human necessities

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#51 | 2006-06-15 ✅ Patent 7,722,903 granted on 2010-05-25
US20060127516A1
Human necessities

Modulation of inflammation by hops fractions and derivatives

#52 | 2006-06-15 ✅ Patent 7,820,206 granted on 2010-10-26
US20060127512A1
Human necessities

Modulation of inflammation by hops fractions and derivatives

#53 | 2005-12-27 ✅ Patent 6,979,470 granted on 2005-12-27
US10198277
-

Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2

#54 | 2005-09-01 ✅ Patent 7,914,831 granted on 2011-03-29
US20050191375A1
Human necessities

Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines

#55 | 2005-06-21 ✅ Patent 6,908,630 granted on 2005-06-21
US9919349
-

Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2

#56 | 2005-02-24 ✅ Patent 7,195,785 granted on 2007-03-27
US20050042317A1
Human necessities

Complex mixtures exhibiting selective inhibition of cyclooxygenase-2

Also check out Metaproteomics, LLC's (San Clemente, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

13748 ⎘